Skip to main content
. 2017 Nov 24;7:16288. doi: 10.1038/s41598-017-16339-9

Table 1.

Subjects demographics.

variables value
age (years), mean ± SD [range] 54.6 ± 12.3 [37 to 77]
gender, male:female 16:6
eye, righ:left 11:11
LogMAR VA, mean ± SD [range] 0.17 ± 0.25 [−0.079 to 0.70]
MS0 (dB), mean ± SD [range] 16.2 ± 5.2 [4.0 to 25.0]
MS2 (dB), mean ± SD [range] 19.6 ± 5.7 [4.9 to 28.8]
MS4 (dB), mean ± SD [range] 20.8 ± 6.0 [4.9 to 29.0]
MS6 (dB), mean ± SD [range] 21.7 ± 5.2 [11.4 to 29.1]
CRT (μm), mean ± SD [range] 331.1 ± 93.1 [213.5 to 507.5]
SRD (μm), mean ± SD [range] 132.6 ± 94.2 [10.0 to 324.0]
MV1 (μm3), mean ± SD [range] 0.27 ± 0.070 [0.18 to 0.41]
MV2 (μm3), mean ± SD [range] 1.16 ± 0.24 [0.82 to 1.71]
MV3 (μm3), mean ± SD [range] 2.58 ± 0.45 [1.92 to 3.69]
CCT (μm), mean ± SD [range] 317.8 ± 79.4 [185.0 to 436.0]
Disease duration (months), mean ± SD [range] 17.4 ± 9.8 [3 to 33]

SD: standard deviation, VA: visual acuity, MS0: mean sensitivity at fovea, MS2: mean sensitivity within two degrees, MS4: mean sensitivity within four degrees, MS6: mean sensitivity within six degrees, SRDH: serous retinal detachment height, CRT: central retinal thickness, MV1: macular volume within 1 mm diameter, MV2: macular volume within 2 mm diameter, MV3: macular volume within 3 mm diameter, CCT: central choroidal thickness, Disease duration was collected from 46 eyes of 40 patients.